IQVIA Holdings | IQV - Interest Expense On Debt


IQVIA Holdings reported $189M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Accenture USD 65.36M 875K Sep/2025
Agilent USD 27M 1000K Sep/2025
Bruker USD 20M 4.3M Sep/2025
Cardinal Health USD 80M 6M Sep/2025
Celltrion KRW 19B 1.96B Jun/2025
Charles River Laboratories USD 25.4M 4.56M Sep/2025
Cigna USD 157.92B 157.58B Sep/2025
Cognizant Technology Solutions USD 8M 1000K Sep/2025
Cspc Pharmaceutical CNY 10.19M 4.73M Sep/2025
CVS Health USD 784M 21M Sep/2025
Danaher USD 55M 12M Dec/2025
Dentsply International USD 23M 1000K Sep/2025
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Divis Laboratories Ltd INR 30M 20M Jun/2025
Elevance Health USD 366M 15M Dec/2025
Hologic USD 27.6M 1000K Dec/2025
Humana USD 168M 11M Sep/2025
IBM USD 478M 14M Dec/2025
Illumina USD 25M 0 Jun/2025
Infosys INR 1000M 60M Dec/2025
Kangmei Pharma CNY 1.82M 150K Sep/2025
Knight Therapeutics CAD 2.37M 6K Sep/2025
Laboratorios Farma EUR 699K 666.2K Jun/2025
Laboratory Of America USD 56M 1.1M Sep/2025
McKesson USD 74M 25M Sep/2025
Mettler Toledo International USD 17.7M 916K Sep/2025
Pharma Mar EUR 117K 1.24M Sep/2025
Publicis EUR 51M 10M Jun/2025
Qiagen NV USD 8.22M 615K Sep/2025
Quest Diagnostics USD 69M 2M Sep/2025
Revvity USD 22.77M 166K Sep/2025
Sartorius EUR 49.5M 8.1M Sep/2025
Sino Biopharmaceutical CNY 76.87M 114.23M Jun/2024
Thermo Fisher Scientific USD 365M 18M Dec/2025
Tilray USD 6.7M 2.73M Jun/2025
UnitedHealth USD 974M 29M Dec/2025
Veeva Systems USD 65.1M 8.4M Mar/2025
Waters USD 26.64M 12.28M Sep/2025
Zz Pientze Pharmaceu CNY 46.05M 36.5M Jun/2025